NCT00418600View on ClinicalTrials.gov

A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

August 31, 2007

Conditions

Secondary Hyperparathyroidism

Interventions

DRUG

Hectorol® (doxercalciferol capsules)

Hectorol capsules at 1.0 times current injection dose

DRUG

doxercalciferol capsules, Hectorol®

Hectorol capsules at 1.5 times current injection dose

DRUG

doxercalciferol capsules, Hectorol® capsules

Hectorol capsules at 2.0 times current injection dose

Trial Locations (8)

Unknown

Hot Springs

Downey

Tarzana

Atlanta

Cincinnati

Pittsburgh

Houston

Spokane

All Listed Sponsors

lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00418600 - A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis | Biotech Hunter | Biotech Hunter